Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Beckman Coulter, Inc. - Medical Equipment - Deals and Alliances Profile

Enquire | Email | Print

ISBN: GDME3D
Published Date: Feb, 2014
Format: PDF
No of Pages: 44
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

Summary

Beckman Coulter, Inc. (Beckman) is a medical device company. It undertakes the manufacture and marketing of biomedical laboratory instruments, software and supplies that simplify, automate and innovate complex biomedical tests. Its products are used in a wide range of applications such as medical research, clinical trials and drug discovery, and diagnostic laboratories in hospitals. The company has three divisions, namely, Research and Discovery, Diagnostics and Industrial. It operates across the US, Canada, Europe and Asia. Its products are sold in over 160 countries worldwide. The company has an installed base of over 275,000 clinical and research systems operating in laboratories around the world. Beckman is a subsidiary of Danaher Corporation, and is headquartered in California, the US.

The company seeks to offer its customers the world's most efficient laboratories that would contribute in improving patient health and at the same time reduce the cost of care. Beckman envisages establishing its position through the development of innovative products and services and enhancement of existing ones, internal development, strong partner relationships, strategic collaborations and acquisitions.

Beckman Coulter, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Beckman Coulter, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Beckman Coulter, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 6
Beckman Coulter, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Beckman Coulter, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 8
Beckman Coulter, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 9
Beckman Coulter, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
Beckman Coulter Acquires Clinical Products Distribution Business From Dong-A Pharma, For US$10 Million 10
Beckman Coulter Acquires Royalty Obligation for Preeclampsia Markers From Nephromics 11
Partnerships 12
Beckman Coulter Enters Into Licensing Agreements With National University Of Ireland 12
CellaVision Expands Distribution Agreement With Beckman Coulter 13
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 14
Atonomics Enters Into An Agreement With Beckman Coulter 15
Transgene Signs Agreement With Beckman Coulter 16
Trillium Diagnostics Enters Into Co-Marketing Agreement With Beckman Coulter 17
CellaVision Enters Into Distribution Agreement With Beckman Coulter 18
Axis-Shield Enters Into An Agreement With Beckman Coulter 19
AcroMetrix Enters Into A Partnership Agreement With Beckman Coulter 20
Beckman Coulter Signs An Agreement With Siemens Healthcare Diagnostics 21
Equity Offering 22
Beckman Coulter Completes Public Offering Of Common Stock For US$250 Million 22
Debt Offering 24
Beckman Coulter Completes Public Offering Of 6% Senior Notes For US$250 Million 24
Beckman Coulter Completes Public Offering Of 7% Senior Notes For US$250 Million 25
Acquisition 26
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 26
Danaher Completes Acquisition Of Beckman Coulter 27
Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 30
Beckman Coulter, Inc. - Key Competitors 32
Key Employees 33
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 39
Legal and Regulatory 39
Nov 12, 2013: Mindray Announced a Settlement Agreement with Beckman Coulter 39
Product News 39
Oct 01, 2013: Navios Flow Cytometer from Beckman Coulter Cleared for Diagnostic Use in U.S. and China 39
Sep 26, 2013: Beckman Coulter Receives FDA Clearance of AccuTnI+3 Troponin I Assay on UniCel DxI Immunoassay Systems 39
Jun 19, 2013: Beckman Coulter Gets FDA 510(k) Clearance For New Access AccuTnI+3 Troponin I Assay 40
Apr 16, 2013: Beckman Coulter Launches UniCel DxH 600 Coulter Cellular Analysis System 40
Apr 05, 2013: Beckman Coulter Gets FDA Clearance For Next Generation Hemoglobin A1c Test 41
Product Approvals 41
Oct 01, 2013: Navios Flow Cytometer from Beckman Coulter Cleared for Diagnostic Use in U.S. and China 41
Sep 26, 2013: Beckman Coulter Receives FDA Clearance of AccuTnI+3 Troponin I Assay on UniCel DxI Immunoassay Systems 42
Jun 19, 2013: Beckman Coulter Gets FDA 510(k) Clearance For New Access AccuTnI+3 Troponin I Assay 42
Apr 05, 2013: Beckman Coulter Gets FDA Clearance For Next Generation Hemoglobin A1c Test 42
Other Significant Developments 43
Apr 17, 2013: Premier Awards New Contracts For Chemistry And Immunochemistry Analyzers, Automation, Reagents, Consumables And Service 43
Apr 03, 2013: Beckman Coulter Signs Six Year Agreement With Premier Healthcare Alliance To Provide Full Range Of Core Laboratory Systems And Supplies 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables

Beckman Coulter, Inc., Medical Equipment, Key Facts 1
Beckman Coulter, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Beckman Coulter, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 6
Beckman Coulter, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Beckman Coulter, Inc., Deals By Market, 2008 to YTD 2014 8
Beckman Coulter, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 9
Beckman Coulter Acquires Clinical Products Distribution Business From Dong-A Pharma, For US$10 Million 10
Beckman Coulter Acquires Royalty Obligation for Preeclampsia Markers From Nephromics 11
Beckman Coulter Enters Into Licensing Agreements With National University Of Ireland 12
CellaVision Expands Distribution Agreement With Beckman Coulter 13
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 14
Atonomics Enters Into An Agreement With Beckman Coulter 15
Transgene Signs Agreement With Beckman Coulter 16
Trillium Diagnostics Enters Into Co-Marketing Agreement With Beckman Coulter 17
CellaVision Enters Into Distribution Agreement With Beckman Coulter 18
Axis-Shield Enters Into An Agreement With Beckman Coulter 19
AcroMetrix Enters Into A Partnership Agreement With Beckman Coulter 20
Beckman Coulter Signs An Agreement With Siemens Healthcare Diagnostics 21
Beckman Coulter Completes Public Offering Of Common Stock For US$250 Million 22
Beckman Coulter Completes Public Offering Of 6% Senior Notes For US$250 Million 24
Beckman Coulter Completes Public Offering Of 7% Senior Notes For US$250 Million 25
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 26
Danaher Completes Acquisition Of Beckman Coulter 27
Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 30
Beckman Coulter, Inc., Key Competitors 32
Beckman Coulter, Inc., Key Employees 33
Beckman Coulter, Inc., Other Locations 35
Beckman Coulter, Inc., Subsidiaries 37

List of Figures

Beckman Coulter, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Beckman Coulter, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 6
Beckman Coulter, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Beckman Coulter, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 8

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 345039, price: INR 15226, GlobalData

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online